Update diabetes guidelines
May 12, 2014
THE summary of the stakeholder
forum for the post market review of
products used in the management
of diabetes, for stage three, or type
2 diabetes medicines, showed a
key discussion point raised was
the confusing nature of current
treatment guidelines for type 2
diabetes.
Held on 12 Sep, the forum heard
that the guidelines reflected PBS
reimbursement criteria and not
current clinical evidence, the
document said.
The summary said some
stakeholders had called for the
treatment guidelines to be updated
to include new evidence and be
consolidated into a single set of
guidelines, which would require
collaboration between peak bodies
and the National Health and Medical
Research Council; however updated
treatment algorithms were being
developed.
“The treatment algorithm should
be evidence-based, patient centred,
easy to implement in clinical
practice, and should make clear the
PBS requirements and criteria for
subsidy.”
The above article was sent to subscribers in Pharmacy Daily's issue from 12 May 14To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 12 May 14
